Market revenue in 2023 | USD 71.3 million |
Market revenue in 2030 | USD 138.4 million |
Growth rate | 9.9% (CAGR from 2023 to 2030) |
Largest segment | Hospitals |
Fastest growing segment | Hospitals |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals |
Key market players worldwide | Merck & Co Inc, Amgen Inc, Roche, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries, Arbor Pharmaceuticals, Amneal Pharmaceuticals, Karyopharm Therapeutics Inc, Sumitomo Dainippon Pharma Oncology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to glioblastoma multiforme treatment market will help companies and investors design strategic landscapes.
Hospitals was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Middle East & Africa glioblastoma multiforme treatment market based on hospitals covering the revenue growth of each sub-segment from 2018 to 2030.
Middle Eastern countries such as Saudi Arabia, Qatar, United Arab Emirates (UAE), Kuwait, and Oman are prospering economies. Advancements in their healthcare systems are expected to increase the demand for cancer therapies in the region.
On the contrary, some countries in Africa lack the required healthcare infrastructure. Rapidly rising elderly population and increased demand for GBM treatment are factors likely to boost market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa glioblastoma multiforme treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa glioblastoma multiforme treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account